Zobrazeno 1 - 10
of 239
pro vyhledávání: '"Adriano, Arguedas"'
Autor:
Qianqian Du, Zhaoqiu Liu, Hongmei Wang, Yani Wang, Li Liu, Xuexia Wen, Sangjie Yu, Qingqing Ren, Elisa Gonzalez, Adriano Arguedas, Mark A. Fletcher, Kaijie Pan, Graciela Del Carmen Morales, Jikui Deng, Kaihu Yao
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
ObjectivesTo describe the carriage rate, serotype distribution, and antimicrobial susceptibility patterns of Streptococcus pneumoniae (S. pneumoniae) nasopharyngeal (NP) isolates among healthy children aged 30 days to
Externí odkaz:
https://doaj.org/article/153de2b5b4d44e0e9447d388c926beff
Autor:
Lindsay R. Grant, Kevin Apodaca, Lalitagauri Deshpande, John H. Kimbrough, Kyla Hayford, Qi Yan, Rodrigo Mendes, Alejandro Cané, Bradford D. Gessner, Adriano Arguedas
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
IntroductionPneumococcal conjugate vaccines (PCVs), including higher valency vaccines such as PCV20, have the potential to reduce pediatric otitis media. We assessed serotype distribution, potential PCV coverage, and antimicrobial susceptibility of S
Externí odkaz:
https://doaj.org/article/fe75c8964f5b4993bea3ea7db5e95ed8
Autor:
Mark H. Rozenbaum, Erica Chilson, Raymond Farkouh, Liping Huang, Alejandro Cane, Adriano Arguedas, Maria J. Tort, Vincenza Snow, Ahuva Averin, Derek Weycker, Dhwani Hariharan, Mark Atwood
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 4, Pp 745-760 (2024)
Abstract Introduction A 20-valent pneumococcal conjugate vaccine (PCV20) was recently recommended for use among US children. We evaluated the cost-effectiveness of PCV20 among children aged 6 years with chronic medical conditions (CMC+) and children
Externí odkaz:
https://doaj.org/article/b712d8278380477ba2012c98d05adfdf
Autor:
Mladen Jovanović, Adriano Arguedas-Soley, Dimitrije Cabarkapa, Håkan Andersson, Dóra Nagy, Nenad Trunić, Vladimir Banković, Répási Richárd, Sandor Safar, Laszlo Ratgeber
Publikováno v:
Sensors, Vol 24, Iss 19, p 6192 (2024)
Sprint performance is commonly assessed via discrete sprint tests and analyzed through kinematic estimates modeled using a mono-exponential equation, including estimated maximal sprinting speed (MSS), relative acceleration (TAU), maximum acceleration
Externí odkaz:
https://doaj.org/article/6f51f1991cf34fb88900f2ace2c6faf4
Autor:
Anne L. Wyllie, Sidiya Mbodj, Darani A. Thammavongsa, Maikel S. Hislop, Devyn Yolda-Carr, Pari Waghela, Maura Nakahata, Anne E. Stahlfeld, Noel J. Vega, Anna York, Orchid M. Allicock, Geisa Wilkins, Andrea Ouyang, Laura Siqueiros, Yvette Strong, Kelly Anastasio, Ronika Alexander-Parrish, Adriano Arguedas, Bradford D. Gessner, Daniel M. Weinberger
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Reported rates of invasive pneumococcal disease were markedly lower than normal during the 2020/2021 winter in the Northern Hemisphere, the first year after the start of the COVID-19 pandemic. However, little is known about rates of carriage
Externí odkaz:
https://doaj.org/article/0f1b1f1e8ab24f75886be4e04a66a036
Autor:
Chih-Ho Chen, Chyi-Liang Chen, Adriano Arguedas, Joanna Southern, Chang-Chun Hsiao, Cheng-Hsun Chiu
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 53, Iss 6, Pp 1035-1038 (2020)
We investigated pneumococcal carriage between children ≦5 years old with otitis media (OM) and those without. Non-PCV13 serotypes were common in both groups; 19A remained the second most common serotype among children with OM despite high PCV13 cov
Externí odkaz:
https://doaj.org/article/2d60992e810f4cb780b896f4b78d1c44
Autor:
Liping Huang, Jennifer L. Nguyen, Tamuno Alfred, Johnna Perdrizet, Alejandro Cane, Adriano Arguedas
Publikováno v:
Infectious Diseases and Therapy. 11:2141-2158
A 13-valent pneumococcal conjugate vaccine (PCV13) was licensed to protect against emerging Streptococcus pneumoniae serotypes. Healthcare services, including routine childhood immunizations, were disrupted as a result of coronavirus disease 2019 (CO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150a949f2afeca6043bd8b5b45589ad4
https://doi.org/10.1007/s40121-022-00699-5
https://doi.org/10.1007/s40121-022-00699-5
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 10, Pp 1007-1027 (2017)
Introduction: Streptococcus pneumoniae causes mucosal and invasive diseases with high morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) into routine infant immunization programs worldwide resulted in serotype
Externí odkaz:
https://doaj.org/article/919f55c366b44349af0d2a461f627f6e
Autor:
Liping, Huang, Matt, Wasserman, Lindsay, Grant, Raymond, Farkouh, Vincenza, Snow, Adriano, Arguedas, Erica, Chilson, Reiko, Sato, Johnna, Perdrizet
Publikováno v:
Vaccine. 40:4700-4708
The addition of pneumococcal conjugate vaccines (PCVs) to the United States (US) national immunization program led to significant reductions in incidence, mortality, and associated sequelae caused by pneumococcal disease (PD) in children and adults t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2016501618ea1bf6f368eb519f2d3d46
https://doi.org/10.1016/j.vaccine.2022.06.024
https://doi.org/10.1016/j.vaccine.2022.06.024
Autor:
Raul Isturiz, Heather L. Sings, Betsy Hilton, Adriano Arguedas, Ralf-Rene Reinert, Bradford Gessner, Luis Jodar
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 8, Pp 669-671 (2018)
Externí odkaz:
https://doaj.org/article/39549c4840af4c02bdd8ff57e2849462